Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-37591288

RESUMEN

OBJECTIVE: The aim of this study is to examine the impact of carbohydrate ratios in the diet consumed one day prior to the 75-g oral glucose screening test on both the screening test values and the diagnosis of gestational diabetes mellitus in the unselective pregnant population. MATERIAL-METHOD: 83 pregnant women who were under observation in the antenatal clinic of our hospital and underwent glucose tolerance tests were included in the study. The patients were given training by a dietitian to keep nutrition records of the day prior to glucose loading during their previous visits before any glucose loading. A carbohydrate intake of 40-60% was considered as the normal range in terms of the percentage of carbohydrates in the diet. A carbohydrate percentage above 60% was considered to be a high carbohydrate intake. The carbohydrate percentages in their diet over the past 24 hours was compared with the effect on the glucose tolerance test. RESULTS: Out of the 83 pregnant women included in the study, 40 of them had a high carbohydrate diet (HCD) prior to the oral glucose tolerance test (OGTT), and the average carbohydrate percentage of this diet was found to be 62%. The remaining 43 patients had an average carbohydrate percentage of 49% and belonged to the group that had a normal carbohydrate diet (NCD). Out of the 83 pregnant women, 33 of them were at high risk for gestational diabetes mellitus (GDM). In the high-risk patient group, 16 patients had an NCD intake, while 17 patients had a HCD intake. It was determined that a high carbohydrate diet had no significant effect on fasting, first-hour, and second-hour glucose levels, as well as the diagnosis of gestational diabetes mellitus (GDM), in both the unselective population and the high-risk patient population. CONCLUSION: In our study, we concluded that the high carbohydrate ratios in the diets of pregnant women one day prior did not affect the OGTT results or the GDM ratios. This indicates that there is no need for a preparatory diet prior to the OGTT in women with normal dietary habits.

2.
Mol Biol Rep ; 48(3): 2163-2171, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33620660

RESUMEN

Gestational choriocarcinoma is aggressive trophoblastic disease. The development, progression and the cure of this disease is not well-established. p97/Valosin containing protein has been shown to play critical roles in many cellular processes. In various cancers, higher expression of p97/VCP has been reported and targeting of p97/VCP with its spesific inhibitors or siRNA's (siVCP) in cancer therapy was suggested. However, no study is avaible about the expression and function of p97/VCP in gestational choriocarcinoma. Hence, the aim of the study was to evaluate effects of p97/VCP inhibitor, DBeQ and siVCP on choriocarcinoma cells. We use human placental choriocarcinoma cell line (Jeg3) as model to find out the effects of DBeQ and VCP siRNA's (siVCP) on apoptotic and autophagic pathway by immunflouroscence staining, Western blotting, qPCR and flow-cytometry. p97/VCP siRNA's and DBeQ induced accumulation of autophagic proteins, LC3II and p62 in the cytoplasm of Jeg3 cells detected. Concurrently, Jeg3 cells treated with DBeQ and siVCP demonstrated G0/G1 cell cycle arrest, accompanied by accumulation of poly-ubiquitinated proteins. Moreover, disruption of p97/VCP by siRNA and DBeQ inhibited cancer cell growth managing the caspases-3 and -7. Our results show that inhibition of p97/VCP activity with DBeQ and depletion of p97/VCP expression with siRNA in Jeg3 cells induce caspase activation, inhibits cell proliferation and leads to a defect in autophagosome maturation, thus providing potential target for the prevention and treatment of choriocarcinoma.


Asunto(s)
Apoptosis , Autofagosomas/metabolismo , Puntos de Control del Ciclo Celular , Coriocarcinoma/metabolismo , Coriocarcinoma/patología , Proteína que Contiene Valosina/metabolismo , Apoptosis/efectos de los fármacos , Autofagosomas/efectos de los fármacos , Autofagia/efectos de los fármacos , Puntos de Control del Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Fase G1/efectos de los fármacos , Humanos , Proteínas Asociadas a Microtúbulos/metabolismo , Poliubiquitina/metabolismo , Quinazolinas/farmacología , ARN Interferente Pequeño/metabolismo , Fase de Descanso del Ciclo Celular/efectos de los fármacos , Proteína Sequestosoma-1/metabolismo , Ubiquitinación/efectos de los fármacos
3.
Int J Gynecol Pathol ; 38(5): 404-413, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30134343

RESUMEN

Chemotherapeutic agents are not very effective in treating advanced endometrial cancers (ECs). Recent studies have demonstrated the immune evasion mechanism of tumors and possible remedies. Programmed cell death protein 1 (PD-1), programmed death ligand 1 (PD-L1), and programmed death ligand 2 (PD-L2) are immunomodulator molecules that have been the focus of research in lung cancer, melanoma, and renal cell cancer. However, there are few studies concerning EC. This retrospective study aimed to determine PD-1, PD-L1, and PD-L2 expression immunohistochemically in EC, and to study their correlation with clinicopathologic tumor characteristics. This study comprised 127 patients with EC. Anti PD-1, PD-L1, and PD-L2 antibodies were examined immunohistochemically on sections obtained from tissue microarray paraffin blocks. No staining with PD-1 in tumor cells was seen; however, we found positive staining in tumor cells at 36.2% with PD-L1 and 64.4% with PD-L2, and at 61.6% with PD-1, 36.2% with PD-L1, and 93.2% with PD-L2 in immune cells. When comparing staining and clinicopathologic findings, most of the PD-L1 negative tumors (both in tumor and immune cells) were FIGO Stage I, which was significantly higher than stage II-III-IV tumors (P<0.05). There was a statistically significant association between the FIGO grade and the PD-L1 score in immune cells (P=0.009), and between staining of PD-1, PD-L1, and PD-L2 and age (P=0.004, 0.013, and 0.043, respectively). Interaction between PD-1, PD-L1, and PD-L2 may be a potential target for immunotherapy in elderly and advanced stage EC patients.


Asunto(s)
Antígeno B7-H1/análisis , Neoplasias Endometriales/patología , Proteína 2 Ligando de Muerte Celular Programada 1/análisis , Receptor de Muerte Celular Programada 1/análisis , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias Endometriales/química , Neoplasias Endometriales/mortalidad , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Estadificación de Neoplasias , Análisis de Matrices Tisulares
4.
J Clin Ultrasound ; 45(5): 277-281, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28271526

RESUMEN

BACKGROUND: The purpose of this study was to evaluate the influence of maternal obesity on the size of the fetal thymus. METHODS: The study population consisted of 138 pregnant women who were divided into two groups based on their body mass index (BMI): Normal-weight group (n = 97; BMI: 18-25 kg/m2 ) and obese group (n = 41; BMI: ≥ 30 kg/m2 ). All participants underwent routine second-trimester prenatal ultrasound (US) screening at 20-25 weeks of gestation. Differences in US measurement of fetal thymus, fetal anthropometric measurements, subcutaneous adipose tissue thickness, fetal weight, gestational age, white blood cell count, and C-reactive protein (CRP) values between groups were compared. RESULTS: The mean thymus size was 18.7 ± 2.9 mm for normal-weight group, and 21.6 ± 3.7 mm for the obese group (p < 0.001). CRP values were also significantly different between groups (6.8 ± 4.4 mg/dl for normal-weight group, 14.8 ± 1.8 mg/dl for obese group, p < 0.001). CONCLUSIONS: Fetal thymus size was increased in obese women, and this increase may indicate immunologic abnormalities in fetuses. However, future large-scale studies are necessary to support this association. © 2016 Wiley Periodicals, Inc. J Clin Ultrasound 45:277-281, 2017.


Asunto(s)
Madres , Obesidad/complicaciones , Complicaciones del Embarazo , Timo/diagnóstico por imagen , Timo/embriología , Ultrasonografía Prenatal/métodos , Adulto , Femenino , Humanos , Tamaño de los Órganos , Embarazo , Timo/crecimiento & desarrollo
5.
J Pak Med Assoc ; 66(4): 435-8, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27122271

RESUMEN

OBJECTIVE: To investigate the effect of high-dose fluoride on antioxidant enzyme activities of amniotic fluid and fluoride of serum in rats. METHODS: The experimental study was conducted from January 8, 2008, to December 14, 2010, at the Suleyman Demirel University Experimental Animals Laboratory and the Medical Biochemistry Department Research Laboratory, Isparta, Turkey. Impregnated Wistar albino rats were divided into two equal groups. Group I had controls, while Group II rats were exposed to high-dose fluoride. Group I was given drinking water mixed with 0.1 mg/kg/b.w./day of natrium fluoride, while group II was given drinking water mixed with 10 mg/kg/b.w./day of natrium fluoride for 18 days. At the end of 18 days, amniotic fluid and blood samples were collected from control and experimental groups of pregnancy. Superoxide dismutase, glutathione peroxidase, catalase activities and thiobarbituric acid reactive substances as antioxidant enzymes in amniotic fluid and levels of fluoride in serum samples were investigated. RESULTS: There were 14 rats, with 7(50%) in each group. Foetal weight in group II significantly decreased compared to the control group (p< 0.05). Antioxidant enzyme activities in amniotic fluid were significantly higher in group II than group I (p< 0.05) although thiobarbituric acid reactive substances in amniotic fluid and serum fluoride levels were significantly lower in group II than group I (p< 0.05). CONCLUSIONS: Fluoride that created oxidative stress inhibited lipid peroxidation and apparently increased the antioxidant defence system.


Asunto(s)
Líquido Amniótico/efectos de los fármacos , Cariostáticos/farmacología , Catalasa/efectos de los fármacos , Glutatión Peroxidasa/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fluoruro de Sodio/farmacología , Superóxido Dismutasa/efectos de los fármacos , Líquido Amniótico/enzimología , Animales , Cariostáticos/administración & dosificación , Catalasa/metabolismo , Femenino , Glutatión Peroxidasa/metabolismo , Embarazo , Ratas , Ratas Wistar , Fluoruro de Sodio/administración & dosificación , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
6.
Reprod Sci ; 29(2): 627-632, 2022 02.
Artículo en Inglés | MEDLINE | ID: mdl-34101147

RESUMEN

The objective of this study is to investigate a possible correlation between anxiety status and anti-Mullerian hormone (AMH) levels among healthcare professionals who provide medical care directly to COVID-19-positive patients during the recent pandemic. Fifty-two healthcare professionals (nurses, midwives, and residents) who provide medical care directly to COVID-19-positive patients in inpatient clinics or intensive care units were enrolled in this study. Serum AMH levels were analyzed to reflect ovarian reserve. The Beck Anxiety Inventory (BAI) and the State-Trait Anxiety Inventory (STAI-S and STAI-T, respectively) were completed by participants to assess their anxiety status. A linear regression model with participant age as the constant variable was applied to analyze the relationship between inventory scale scores and AMH levels. P-values less than 0.05 were considered statistically significant. The mean AMH value was significantly lower for the participants in the moderate/severe anxiety group compared to the minimal/mild anxiety group (p = 0.007). A linear regression analysis revealed a significant negative correlation between AMH levels and both BAI (B = -0.030, standard error = 0.010, p = 0.004) and STAI-S and STAI-T scores when age was controlled (both p = 0.003). The severity of anxiety experienced during the recent COVID-19 pandemic among healthcare professionals, who provide medical care directly to COVID-19-positive patients, is found to be related to low AMH levels.


Asunto(s)
Hormona Antimülleriana/sangre , Ansiedad/sangre , COVID-19 , Internado y Residencia , Partería , Personal de Enfermería en Hospital , Adulto , Ansiedad/diagnóstico , Ansiedad/psicología , Biomarcadores/sangre , Regulación hacia Abajo , Femenino , Humanos , Reserva Ovárica , Valor Predictivo de las Pruebas , Medición de Riesgo , Factores de Riesgo , Índice de Severidad de la Enfermedad , Adulto Joven
7.
J Chin Med Assoc ; 81(9): 825-829, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29033107

RESUMEN

BACKGROUND: The aim was to compare serum soluble urokinase-type plasminogen activator receptor (suPAR) levels as well as interleukin-6 levels (IL-6) in pregnant women with hyperemesis gravidarum (HG) and asymptomatic pregnant women. METHODS: Our study population consists of voluntary first trimester-pregnant women who applied to the outpatient clinic of the department of obstetrics and gynecology of Ankara Ataturk Training and Research Hospital. Between February and May 2016, 60 pregnant women were included in our prospective study. Serum suPAR and IL-6 levels were evaluated with the ELISA method. Twenty-nine pregnant women with HG and 31 asymptomatic pregnant women were included in the study. RESULTS: Serum suPAR level in the HG group was measured as 0.36 ± 0.56 ng/ml, whereas this level in the healthy pregnant control group was measured as 0.15 ± 0.15 ng/ml (p < 0.05). The interleukin-6 level in the HG group was 5.69 ± 2.16 pg/ml, whereas in the control group it was measured as 3.88 ± 0.28 pg/ml (p < 0.05). CONCLUSION: Serum suPAR and IL-6 levels proved to be high in the HG group. It is likely that suPAR could play a role in the etiopathogenesis of hyperemesis gravidarum.


Asunto(s)
Hiperemesis Gravídica/sangre , Interleucina-6/sangre , Receptores del Activador de Plasminógeno Tipo Uroquinasa/sangre , Adulto , Femenino , Humanos , Hiperemesis Gravídica/etiología , Embarazo , Receptores del Activador de Plasminógeno Tipo Uroquinasa/fisiología , Tirotropina/sangre
8.
J Matern Fetal Neonatal Med ; 28(15): 1828-32, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25260128

RESUMEN

OBJECTIVE: Maternal vitamin D deficiency is a major public health problem. The aim of this study is to investigate the influence of vitamin D deficiency on perinatal results in primigravida. METHODS: One-hundred fifty-two healthy nullipar women were included in the study. Pregnant women with serum vitamin D levels <15ng/ml were defined as Group I and ≥15 ng/dl were defined as Group II; data were evaluated retrospectively. Type of delivery, gestational age at birth, birth weight, intensive care of the newborn, peri-and postpartum complications were recorded. Statistical analyses were performed with SPSS for Windows (version 16.0 ). Categorical variables were assessed using chi-squared test. The numeric variables were analyzed using Student's t-test and one-way ANOVA. RESULTS: 44.6% of pregnant women were found to have vitamin D deficiency. The mean serum vitamin D levels for Groups I and II were 10.8 ± 3.8 and 23.8 ± 13.3 ng/ml, respectively. SGA deliveries were detected in 16.66% and 4.87% of the primigravidas with and without vitamin D deficiency, respectively. CONCLUSIONS: This study has shown that maternal vitamin D deficiency is related with an increased risk of SGA delivery. Further studies are needed to explain the relationship with vitamin D deficiency and poor perinatal outcomes.


Asunto(s)
Complicaciones del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Deficiencia de Vitamina D/epidemiología , Adulto , Peso al Nacer , Parto Obstétrico/métodos , Parto Obstétrico/estadística & datos numéricos , Femenino , Humanos , Recién Nacido , Masculino , Embarazo , Prevalencia , Turquía/epidemiología , Vitamina D/sangre , Deficiencia de Vitamina D/sangre , Adulto Joven
9.
Int. j. morphol ; 35(2): 629-636, June 2017. ilus
Artículo en Inglés | LILACS | ID: biblio-893032

RESUMEN

Fetal period of time during which the fetus grows rapidly and the organs are formed. The prenatal and postnatal analyses of the fetal structure provide information as to fetal growth, growth retardation, gestational age and congenital malformations. The development of the skeletal system during the intrauterine period takes place in an orderly manner as it also does in other systems. It was aimed that the morphometric development of the forearm in human fetuses during the period between 20-40 gestational weeks be radiologically investigated and that its clinical importance be evaluated, as well. A total of 100 fetal forearms (50 fetuses: 23 male, 27 female), the ages of which varied between 20-40 gestational weeks, without having any external pathology or anomaly were incorporated into the study. The fetuses were separated into groups according to weeks, trimesters and months. After the general external measurements of the fetuses had been performed, the mammographies and forearm radiographies of the fetuses were shot in the way that the forearms would remain in a prone position. Morphometric measurements pertaining to forearm structures were taken from the forearm radiographies that were shot with the help of a digital compass. Later on, the morphometric measurements in question were statistically evaluated. The mean values and the standard deviations of the measured parameters were determined according to gestational weeks, trimesters and months. There was a significant correlation between the measured parameters and the gestational age (p<0.001). In the comparison of the measured parameters between trimesters and months, it was observed that there was a statistically significant difference between the groups (p<0.05). Separately, it was also determined that there was no statistically significant difference in the comparison of the parameters, which was made between genders and right-left forearms (p>0.05). As for the results obtained in our study, we are of the opinion that the data obtained during this study period will be beneficial for the involved clinicians, such as those in charge of gynecology, radiology, forensic medicine and perinatology, in terms of evaluating the clinical studies related to the morphometric development of the forearm throughout the fetal period, in determining the fetal age and sex, and also in determining the pathologies and variations regarding the development of fetal skeletal system.


El período fetal es el tiempo en el cual el feto crece rápidamente y se forman los órganos. Los análisis prenatal y postnatal de la estructura fetal proporcionan información sobre el crecimiento fetal, el retraso de crecimiento, la edad gestacional y las malformaciones congénitas. El desarrollo del sistema esquelético, como también el de otros sistemas durante el período intrauterino, avanza de manera ordenada. Se investigó radiológicamente el desarrollo morfométrico del antebrazo en fetos humanos durante el período comprendido entre 20-40 semanas gestacionales y se evaluó su importancia clínica. Un total de 100 antebrazos fetales (50 fetos: 23 de sexo masculino, 27 de sexo femenino), cuya edad varió entre 20-40 semanas de gestación, sin patología externa o anomalía, fueron incluidos en el estudio. Los fetos fueron separados en grupos de semanas, trimestres y meses. Después de realizar las mediciones externas generales de los fetos, las mamografías y las radiografías fueron realizadas de tal manera que los antebrazos permanecieran en pronación. Las radiografías de las medidas morfométricas correspondientes a las estructuras del antebrazo se tomaron con apoyo de una compás digital; posteriormente, las medidas fueron tratadas estadísticamente. Los valores medios y las desviaciones estándar de los parámetros medidos se determinaron de acuerdo con las semanas de gestación, los trimestres y los meses. Hubo una correlación significativa entre los parámetros medidos y la edad gestacional (p <0,001). En la comparación de los parámetros medidos entre los trimestres y los meses, se observó una diferencia estadísticamente significativa entre los grupos (p <0,05). Se determinó también que no hubo diferencias estadísticamente significativas en la comparación de los parámetros, que se realizó entre los sexos y los antebrazos derecho-izquierdo (p> 0,05). En cuanto a los resultados de nuestro estudio, los datos obtenidos durante este período de estudio serán beneficiosos para los clínicos, como también para profesionales de las áreas de ginecología, radiología, medicina forense y perinatología, en la evaluación de estudios clínicos relacionados con el desarrollo morfométrico del antebrazo durante todo el período fetal, determinación de la edad y el sexo fetal, así como en la determinación de variaciones en el desarrollo del sistema esquelético fetal.


Asunto(s)
Humanos , Masculino , Femenino , Embarazo , Desarrollo Embrionario y Fetal , Antebrazo/diagnóstico por imagen , Antebrazo/embriología , Esqueleto/embriología
10.
Fertil Steril ; 89(3): 732-5, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17517398

RESUMEN

The aim of this study was to assess the possible protective effect of sphingosine-1-phosphate (S1P), a polar sphingoid metabolite that seemingly promotes cell survival, on cytotoxin- and irradiation-induced ovarian injury in the rat model. Administration of S1P into ovarian bursa before whole-body irradiation led to decreased percentage of apoptotic cells, mostly in primordial follicles; however, S1P was not effective against apoptosis in rats that were given intraperitoneal cyclophosphamide.


Asunto(s)
Lisofosfolípidos/metabolismo , Enfermedades del Ovario/prevención & control , Folículo Ovárico/metabolismo , Traumatismos Experimentales por Radiación/prevención & control , Esfingosina/análogos & derivados , Animales , Antineoplásicos Alquilantes/administración & dosificación , Apoptosis , Ciclofosfamida/administración & dosificación , Modelos Animales de Enfermedad , Femenino , Inyecciones Intraperitoneales , Enfermedades del Ovario/inducido químicamente , Enfermedades del Ovario/metabolismo , Folículo Ovárico/patología , Inducción de la Ovulación , Traumatismos Experimentales por Radiación/etiología , Traumatismos Experimentales por Radiación/metabolismo , Traumatismos Experimentales por Radiación/patología , Ratas , Ratas Wistar , Esfingosina/metabolismo , Irradiación Corporal Total/efectos adversos
11.
J Obstet Gynaecol Res ; 31(5): 389-93, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16176505

RESUMEN

AIM: To compare vaginally administered misoprostol to rectally administered misoprostol and placebo in a prospective randomized placebo-controlled study. METHODS: One hundred and fifty women with singleton vaginal deliveries were randomized (50 women in each arm) to receive 400-microg misoprostol tablets (crushed and suspended in a microenema) intravaginally, or 400-microg misoprostol tablets rectally, or two placebo lactose tablets rectally. The medication was administered immediately after delivery of the placenta. Women with profuse hemorrhage and delayed placental separation (>30 min) were excluded. Our outcome measures were postpartum blood loss 1 h after administration, and change in hemoglobin and hematocrit values from baseline to postpartum day 1. Analysis of variance and chi-squared tests were used to compare the outcome variables between groups. RESULTS: One hundred and twenty-six women were available for analysis. Baseline characteristics were similar across the groups. The number of excluded subjects, the estimated blood loss, and the drop in hemoglobin and hematocrit values did not differ between the three groups (P > 0.05). CONCLUSIONS: Misoprostol administered vaginally or rectally at a dosage of 400 microg following placental separation was not effective for decreasing postpartum bleeding in women without excessive hemorrhage.


Asunto(s)
Misoprostol/administración & dosificación , Oxitócicos/administración & dosificación , Hemorragia Posparto/prevención & control , Administración Intravaginal , Administración Rectal , Adulto , Femenino , Hematócrito , Hemoglobinas/metabolismo , Humanos , Hemorragia Posparto/sangre , Embarazo , Estudios Prospectivos , Estadísticas no Paramétricas
12.
Gynecol Oncol ; 94(1): 229-31, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15262149

RESUMEN

BACKGROUND: Primary ovarian fibrosarcoma is a very rare tumor. Its Doppler waveform characteristics have not been described before. CASE: A 35-year-old woman presented with a 5-cm solid ovarian mass. Intratumoral artery resistance index (RI) and pulsatility index (PI) were very low (0.19 and 0.21, respectively). Peak systolic velocity calculated by using transvaginal Doppler ultrasound was higher than expected (24.8 cm/s). Postoperatively, the histopathologic diagnosis was primary ovarian fibrosarcoma, stage Ia. CONCLUSIONS: Low vascular resistance can be encountered in ovarian fibrosarcomas. In young patients presenting with a solid adnexal mass, intratumoral Doppler waveform investigations might offer some help for earlier prediction of rare malignant tumors like fibrosarcomas.


Asunto(s)
Fibrosarcoma/diagnóstico por imagen , Neoplasias Ováricas/diagnóstico por imagen , Adulto , Femenino , Fibrosarcoma/irrigación sanguínea , Fibrosarcoma/patología , Humanos , Neoplasias Ováricas/irrigación sanguínea , Neoplasias Ováricas/patología , Ultrasonografía Doppler en Color , Resistencia Vascular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA